Reuters logo
3 个月内
BRIEF-Adverum Biotechnologies says delivered notice to Regenxbio
2017年4月21日 / 晚上8点39分 / 3 个月内

BRIEF-Adverum Biotechnologies says delivered notice to Regenxbio

1 分钟阅读

April 21 (Reuters) - Adverum Biotechnologies Inc:

* Adverum Biotechnologies - on april 19, co delivered a notice to Regenxbio Inc to terminate license agreement dated october 20, 2015 - sec filing

* License agreement, dated october 20, 2015, is between Regenxbio and Annapurna Therapeutics Limited

* Adverum Biotechnologies-does not expect license agreement termination to affect development of advm-043 product candidate for alpha-1 antitrypsin deficiency Source text - bit.ly/2ouYKGd Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below